We are live on ! Find out more
GA

General Atlantic Portfolio holdings

AUM $2.15B
1-Year Est. Return 35.02%
This Fund
S&P 500
This Quarter Est. Return
+10.46%
1 Year Est. Return
+35.02%
3 Year Est. Return
+185.68%
5 Year Est. Return
+122.28%
10 Year Est. Return
+1,080.07%
AUM
$6.48B
AUM Growth
+$134M
Cap. Flow
-$178M
Cap. Flow %
-2.75%
Top 10 Hldgs %
87.36%
Holding
30
New
–
Increased
2
Reduced
3
Closed
1

Top Buys

Rank Stock Value
1
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$48.8M
2
SLRN
ACELYRIN
SLRN
+$29.5M

Top Sells

Rank Stock Value
1
SQSP
Squarespace, Inc.
SQSP
+$176M
2
DNA icon
Ginkgo Bioworks
DNA
+$60.1M
3
YOU icon
Clear Secure
YOU
+$19.6M
4
FUTU icon
Futu Holdings
FUTU
+$225K

Sector Composition

Rank Sector Weight
1 Technology 60.1%
2 Healthcare 16.08%
3 Financials 11.53%
4 Industrials 4.71%
5 Consumer Staples 4.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESMT
1
DELISTED
EngageSmart, Inc.
ESMT
$1.62B 25.07%
90,271,540
– –
DLO icon
2
dLocal
DLO
$4.33B
$1.23B 18.91%
63,906,695
– –
XP icon
3
XP
XP
$8.5B
$683M 10.54%
29,617,733
– –
SQSP
4
DELISTED
Squarespace, Inc.
SQSP
$481M 7.43%
16,611,073
-5,750,000
-26% -$176M
ALHC icon
5
Alignment Healthcare
ALHC
$3.73B
$423M 6.53%
60,993,323
– –
ALKT icon
6
Alkami Technology
ALKT
$1.96B
$341M 5.27%
18,729,806
– –
HRT
7
DELISTED
HireRight Holdings Corporation
HRT
$305M 4.71%
32,109,898
– –
EWCZ
8
DELISTED
European Wax Center
EWCZ
$212M 3.28%
13,110,492
– –
MBLY icon
9
Mobileye
MBLY
$2.04B
$198M 3.05%
4,761,905
– –
KRTX
10
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$167M 2.58%
986,710
+259,752
+36% +$48.8M
DUOL icon
11
Duolingo
DUOL
$6.53B
$96.3M 1.49%
580,642
– –
PHVS icon
12
Pharvaris
PHVS
$2.34B
$92M 1.42%
4,406,252
– –
AKRO
13
DELISTED
Akero Therapeutics
AKRO
$90.3M 1.39%
1,785,714
– –
YOU icon
14
Clear Secure
YOU
$5.71B
$75.7M 1.17%
3,977,442
-883,678
-18% -$19.6M
HCM icon
15
HUTCHMED
HCM
$1.96B
$67.8M 1.05%
4,000,000
– –
FUTU icon
16
Futu Holdings
FUTU
$14.4B
$64M 0.99%
1,107,327
-4,217
-0.4% -$225K
CNTA
17
DELISTED
Centessa Pharmaceuticals
CNTA
$62.6M 0.97%
9,681,818
– –
ARCE
18
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
$56.5M 0.87%
4,103,366
– –
IMCR icon
19
Immunocore
IMCR
$1.7B
$49.3M 0.76%
950,000
– –
RPRX icon
20
Royalty Pharma
RPRX
$26.6B
$40.7M 0.63%
1,500,000
– –
SLRN
21
DELISTED
ACELYRIN
SLRN
$29.4M 0.45%
2,889,668
+1,389,668
+93% +$29.5M
BLND icon
22
Blend Labs
BLND
$433M
$26.2M 0.4%
19,132,440
– –
RSKD icon
23
Riskified
RSKD
$731M
$23.9M 0.37%
5,324,998
– –
THRD
24
DELISTED
Third Harmonic Bio
THRD
$18.9M 0.29%
2,958,762
– –
OPEN icon
25
Opendoor
OPEN
$3.76B
$16.7M 0.26%
6,532,236
– –
1
2

Similar funds

NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return
AAP
Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return
RFP
Root Financial Partners Encinitas, California $2.16B AUM 18.08% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

General Atlantic's Q3 2023 Portfolio in Review

As of Q3 2023, General Atlantic held 30 positions worth $6.48B, up 2.1% from $6.34B the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 3.3%. General Atlantic opened no new positions and exited 1, leaving the 30-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 60% of assets, up from 59% a quarter earlier, followed by Healthcare and Financials.

  • General Atlantic added most to Karuna Therapeutics, Inc. Common Stock in Q3 2023, an estimated $48.8M increase.
  • General Atlantic's biggest Q3 2023 reduction was Squarespace, Inc., cutting an estimated $176M.
  • General Atlantic fully exited Ginkgo Bioworks in Q3 2023, selling an estimated $60.1M.
  • General Atlantic's ten largest holdings make up 87% of its $6.48B portfolio in Q3 2023.
  • General Atlantic opened 0 new positions and closed 1 in Q3 2023.
  • General Atlantic's portfolio value rose 2.1% quarter-over-quarter to $6.48B.

Based on General Atlantic's 13F filing for Q3 2023, filed 14 Nov 2023.